Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)

Open Angle Glaucoma (OAG)Ocular Hypertension (OH)

~Estimated

~$10 – $1,050

Glaukos CorporationNCT07400926

Observational

Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial

This randomized, single-masked, crossover, non-inferiority trial aims to evaluate the safety and efficacy of Nanodropper-mediated microdrops of ocular hypotens…

Ocular HypertensionPrimary Open Angle Glaucoma

~Estimated

~$10 – $7,500

59th Medical WingNCT05844384

Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Medication Burden in Medically Controlled Patients With Ocular Hypertension or Primary Open Angle Glaucoma

This is a prospective, single arm, open label study conducted at a single site to evaluate the efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in red…

Primary Open Angle GlaucomaOcular Hypertension

~Estimated

~$10 – $1,125

The Eye Institute of West FloridaNCT07390890

Observational

An Observer-Masked, Single-Arm, Multicenter Study to Evaluate the Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy

The goal of this clinical trial is to show non-inferiority of the MIMS® device/procedure with Mitomycin-C, in terms of its surgical success rate, compared to t…

Primary Open Angle GlaucomaOpen Angle Glaucoma

~Estimated

~$10 – $8,750

Sanoculis LtdNCT06313749

← PreviousPage 3 of 3Next →